Anna Tomkiewicz
Wroclaw, DS, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Cardiometabolic disease risk: the joint role of the UCP1, UCP2, UCP3, and FTO gene variants.
Journal: Biochimie
Published: June 07, 2026
Polymorphisms in immune checkpoint genes might influence bladder cancer risk and clinical outcome.
Journal: Human immunology
Published: January 12, 2026
Soluble immune checkpoints as diagnostic biomarkers in bladder cancer.
Journal: Biomarker research
Published: September 19, 2025
The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis.
Journal: International journal of molecular sciences
Published: November 29, 2022
Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
Journal: Journal of immunology research
Published: November 28, 2019
Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy.
Journal: Central-European journal of immunology
Published: December 25, 2018
PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.
Journal: Journal of neuroimmunology
Published: October 14, 2016
Last Updated: 09/26/2026